Status:

UNKNOWN

Identifying Unique Scent Signature of Lung Cancer Through Body Odor

Lead Sponsor:

Sheba Medical Center

Conditions:

Lung Neoplasms

Eligibility:

All Genders

Brief Summary

The purpose of this study is to show that dogs are able to detect cancer in sweat samples. This potentially would be the base for developing a new efficient, non invasive and inexpensive diagnosis too...

Detailed Description

Among all cancers which harm the population, lung cancer is the most lethal type, responsible for 1.3 million deaths per year worldwide, for 28% of all cancer deaths.The 5 year survival rates are low,...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • • A diagnosis of lung cancer, regardless of histology.
  • Exclusion Criteria
  • Inability to comply with study and/or follow up procedure.
  • Co morbidity of lung cancer and an additional malignancy combined.
  • Patients taking part in another clinical trial and receiving any treatment for it.

Exclusion

    Key Trial Info

    Start Date :

    February 1 2012

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ESTIMATED

    End Date :

    Estimated Enrollment :

    100 Patients enrolled

    Trial Details

    Trial ID

    NCT01527461

    Start Date

    February 1 2012

    Last Update

    June 4 2013

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Sheba Medical Center

    Tel Hasomer, Israel, 52621